ClinConnect ClinConnect Logo
Search / Trial NCT06897007

Changes in Ciprofol Dosage in Insomnia Patients Undergoing Digestive Endoscopy

Launched by BEIJING TIANTAN HOSPITAL · Mar 20, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Insomnia Digestive Endoscopy Ciprofol

ClinConnect Summary

The investigators aim to investigate whether ciprofol dosage requirement is increased in patients with insomnia undergoing digestive endoscopy compared with normal sleep patterns.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with insomnia:
  • 1. Age of 18 - 64 years;
  • 2. ASA physical status of I - II;
  • 3. BMI of 15 - 30;
  • 4. Scheduled for digestive endoscopy under intravenous anesthesia;
  • 5. Positive screening results according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for insomnia disorder;
  • 6. 8-item Sleep Condition Indicator (SCI; score 0-4; range 0-32, higher score means better sleep) scored 16 or less;
  • * Patients with normal sleep:
  • 1. Age of 18 - 64 years;
  • 2. ASA physical status of I - II;
  • 3. BMI of 15 - 30;
  • 4. Scheduled for digestive endoscopy under intravenous anesthesia;
  • 5. No history or evidence of insomnia.
  • Exclusion Criteria:
  • 1. Associated with any neurological disease;
  • 2. Daily alcohol consumption;
  • 3. Any contraindication to intravenous anesthetic drug, such as hypotension or shock;
  • 4. History of allergy to any drug used in the study;
  • 5. Pregnancy or breastfeeding;
  • 6. Patients with sleep apnea syndrome;
  • 7. acute upper respiratory infection;
  • 8. Patients with psychological diseases who report suicidal thoughts;
  • 9. Patients who need to work or take care of children/elderly people frequently at night.

About Beijing Tiantan Hospital

Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported